Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.98 EUR | -1.80% | +4.27% | -1.21% |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.21% | 11.19B | - | ||
+15.68% | 132B | A- | ||
-8.81% | 8.08B | C | ||
+42.76% | 5.7B | B+ | ||
-17.67% | 4.91B | C | ||
+7.67% | 3.42B | C- | ||
-19.40% | 2.45B | B- | ||
-15.33% | 2.02B | - | - | |
-16.30% | 1.89B | - | ||
-30.89% | 1.61B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SN. Stock
- NPW1 Stock
- Ratings Smith & Nephew Plc